Mordwinkin Nicholas Michael 4
4 · Kezar Life Sciences, Inc. · Filed Aug 2, 2022
Insider Transaction Report
Form 4
Mordwinkin Nicholas Michael
Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-08-01+200,000→ 200,000 totalExercise: $9.35Exp: 2032-07-31→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]Twenty five percent (25%) of the shares will vest on July 11, 2023, and 1/48th of the total shares will vest each month thereafter, subject to Reporting Person continuing to provide service through such date.